Market Cap 27.13M
Revenue (ttm) 640,000.00
Net Income (ttm) -57.78M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -9,028.13%
Debt to Equity Ratio 0.00
Volume 282,549
Avg Vol 177,180
Day's Range N/A - N/A
Shares Out 42.24M
Stochastic %K 30%
Beta -1.05
Analysts Sell
Price Target $1.00

Company Profile

Rallybio Corporation, a clinical-stage biotechnology company, engages in development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody which is in Phase II clinical trial for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT); and RLYB211 for the prevention of FNAIT. The company is also developing RLYB114, a pegylated complement factor 5 (C5)-tar...

Industry: Biotechnology
Sector: Healthcare
Phone: 203 859 3820
Address:
234 Church Street, Suite 1020, New Haven, United States
skyrockets_Inc
skyrockets_Inc Feb. 3 at 9:42 PM
$RLYB Get ready for the nano-float on Friday :) "The reverse stock split is intended to give Rallybio greater flexibility in considering and PLANNING FOR FUTURE POTENTIAL BUSINESS NEEDS and to increase the per share trading price of the Rallybio common stock to enable Rallybio to satisfy the minimum price requirement for continued listing on the Nasdaq Capital Market" PIPE funding w/ nano-float sends this to Jupiter
1 · Reply
skyrockets_Inc
skyrockets_Inc Feb. 3 at 7:58 PM
$RLYB R/S this Friday. Then hopefully news within the following two weeks afterwards. Absolute last patient should be done w/ 10 week follow up by Feb 24 week. Analysis out possible outcomes below still stands and stock has been holding price. I've added more.
0 · Reply
joe77w
joe77w Feb. 1 at 2:00 PM
$RLYB https://clinicaltrials.gov/study/NCT06797375
0 · Reply
joe77w
joe77w Jan. 31 at 1:35 AM
$RLYB any deal happening would be minimal for 10 USD consideration Just my opinion, investors Will Chase stock when and if news out, lets Hope well! Since dec19 within 60 trading days shares (options) become exercisable. Its a matter of patience and we should receive the hoped news about deal and trial data!🤞
0 · Reply
joe77w
joe77w Jan. 31 at 1:29 AM
$RLYB 7 USD in cash After reverse split occurred on fully diluted basis
0 · Reply
estatebuyersmia
estatebuyersmia Jan. 30 at 10:41 PM
$RLYB NO DEAL... HOPIUM.... I WAS RIGHT
1 · Reply
estatebuyersmia
estatebuyersmia Jan. 30 at 10:40 PM
$RLYB MY TAKE, THE STOCK DRIFTS UNTIL DATA RELEASE
0 · Reply
skyrockets_Inc
skyrockets_Inc Jan. 30 at 7:22 PM
$RLYB Enter now while you can, next Friday after 1:8 R/S OS will be 5.25m and free float less than 1M (81% locked up w/ tutes and insiders), will be very difficult to build your position after R/S.
0 · Reply
skyrockets_Inc
skyrockets_Inc Jan. 30 at 12:37 AM
$RLYB R/S is happening Feb 6 (latest possible date) and for only 1:8 split, reducing our OS from 42m to 5.25m shares. Data is more than a month behind schedule so the likely outcomes are now as follows (from most likely to least IMO): 1). Good data drop w/ concurrent PIPE financing announcement --> company continues stand alone --> stock explodes 2). Good data drop, stock trades much higher and they announce offering AH to raise money --> company continues stand alone --> stock trades higher 3). Buyout / asset sale. Still on the table even with upcoming split if terms of deal couldn't be finalized before Feb 6. Split would then have to happen just to keep us listed on NASDAQ until terms finalized --> stock EXPLODES 4). Reverse merger --> depending on terms of deal could trade sideways or x2+ based on previous similar RM's I've been involved in lately (BRNS, VYNE, etc). 5). Bad data, announce strategic alternatives --> stock maintains based on cash position and strat alt annoucement.
1 · Reply
skyrockets_Inc
skyrockets_Inc Jan. 29 at 10:33 PM
$RLYB Deal thesis off the table? LOL. Not even. R/S had to happen in 2 out of the 3 scenarios. If they are RM'ing or releasing data and PIPEing then both would need R/S. They HAVE to do R/S by Feb 9, so any deal taking place after that will require the R/S. This has been known and repeated many times. If you truly believe this means 'deal off table' I'm expecting you will be selling your shares tomorrow. I will gladly buy them off of you :)
1 · Reply
Latest News on RLYB
Rallybio Announces Reverse Stock Split of Common Stock

Feb 3, 2026, 4:05 PM EST - 22 hours ago

Rallybio Announces Reverse Stock Split of Common Stock


Why Is Microcap Rallybio Stock Trading Higher On Tuesday?

Jul 8, 2025, 9:44 AM EDT - 7 months ago

Why Is Microcap Rallybio Stock Trading Higher On Tuesday?


National Vision Releases 2023 Sustainability Report

Aug 27, 2024, 8:00 AM EDT - 1 year ago

National Vision Releases 2023 Sustainability Report

ACNT


Rallybio to Present at Upcoming Investor Conferences

Aug 27, 2024, 8:00 AM EDT - 1 year ago

Rallybio to Present at Upcoming Investor Conferences


skyrockets_Inc
skyrockets_Inc Feb. 3 at 9:42 PM
$RLYB Get ready for the nano-float on Friday :) "The reverse stock split is intended to give Rallybio greater flexibility in considering and PLANNING FOR FUTURE POTENTIAL BUSINESS NEEDS and to increase the per share trading price of the Rallybio common stock to enable Rallybio to satisfy the minimum price requirement for continued listing on the Nasdaq Capital Market" PIPE funding w/ nano-float sends this to Jupiter
1 · Reply
skyrockets_Inc
skyrockets_Inc Feb. 3 at 7:58 PM
$RLYB R/S this Friday. Then hopefully news within the following two weeks afterwards. Absolute last patient should be done w/ 10 week follow up by Feb 24 week. Analysis out possible outcomes below still stands and stock has been holding price. I've added more.
0 · Reply
joe77w
joe77w Feb. 1 at 2:00 PM
$RLYB https://clinicaltrials.gov/study/NCT06797375
0 · Reply
joe77w
joe77w Jan. 31 at 1:35 AM
$RLYB any deal happening would be minimal for 10 USD consideration Just my opinion, investors Will Chase stock when and if news out, lets Hope well! Since dec19 within 60 trading days shares (options) become exercisable. Its a matter of patience and we should receive the hoped news about deal and trial data!🤞
0 · Reply
joe77w
joe77w Jan. 31 at 1:29 AM
$RLYB 7 USD in cash After reverse split occurred on fully diluted basis
0 · Reply
estatebuyersmia
estatebuyersmia Jan. 30 at 10:41 PM
$RLYB NO DEAL... HOPIUM.... I WAS RIGHT
1 · Reply
estatebuyersmia
estatebuyersmia Jan. 30 at 10:40 PM
$RLYB MY TAKE, THE STOCK DRIFTS UNTIL DATA RELEASE
0 · Reply
skyrockets_Inc
skyrockets_Inc Jan. 30 at 7:22 PM
$RLYB Enter now while you can, next Friday after 1:8 R/S OS will be 5.25m and free float less than 1M (81% locked up w/ tutes and insiders), will be very difficult to build your position after R/S.
0 · Reply
skyrockets_Inc
skyrockets_Inc Jan. 30 at 12:37 AM
$RLYB R/S is happening Feb 6 (latest possible date) and for only 1:8 split, reducing our OS from 42m to 5.25m shares. Data is more than a month behind schedule so the likely outcomes are now as follows (from most likely to least IMO): 1). Good data drop w/ concurrent PIPE financing announcement --> company continues stand alone --> stock explodes 2). Good data drop, stock trades much higher and they announce offering AH to raise money --> company continues stand alone --> stock trades higher 3). Buyout / asset sale. Still on the table even with upcoming split if terms of deal couldn't be finalized before Feb 6. Split would then have to happen just to keep us listed on NASDAQ until terms finalized --> stock EXPLODES 4). Reverse merger --> depending on terms of deal could trade sideways or x2+ based on previous similar RM's I've been involved in lately (BRNS, VYNE, etc). 5). Bad data, announce strategic alternatives --> stock maintains based on cash position and strat alt annoucement.
1 · Reply
skyrockets_Inc
skyrockets_Inc Jan. 29 at 10:33 PM
$RLYB Deal thesis off the table? LOL. Not even. R/S had to happen in 2 out of the 3 scenarios. If they are RM'ing or releasing data and PIPEing then both would need R/S. They HAVE to do R/S by Feb 9, so any deal taking place after that will require the R/S. This has been known and repeated many times. If you truly believe this means 'deal off table' I'm expecting you will be selling your shares tomorrow. I will gladly buy them off of you :)
1 · Reply
BiotechValues
BiotechValues Jan. 29 at 10:23 PM
$RLYB knew it. 1:8 RS effective next Friday. Deal thesis off table, but hopefully they pump data later in Feb or March with 5M shares tiny float..
0 · Reply
skyrockets_Inc
skyrockets_Inc Jan. 29 at 9:38 PM
$RLYB Don't forget.... Company is only burning 3M per quarter since the workforce reduction in May. End of Sept, co. had 63M in stockholder equity so it's safe to assume now at the end of Jan probably have 59M. With 42m shares outstanding this equates to a liquidation book value of 1.40/share giving ZERO value to assets RLYB116 or Preclinical assets RLYB332 and RLYB114. Don't forget still are owed 5M more payment from Recursion for REV102. And we are currently trading at 0.65/share! Such a ridiculous value I had to add more shares today. News on the horizon and most likely is either buyout/asset sale, RM, or data readout w/ PIPE funding. Any resolution is a good one at these prices IMO!
0 · Reply
skyrockets_Inc
skyrockets_Inc Jan. 29 at 6:39 PM
$RLYB Possible R/S on the table and yet this is up 7% on a day where every other biotech is red. Yeah, like I said before R/S is a non-issue and smart investors know this. Hopefully news Monday :)
0 · Reply
skyrockets_Inc
skyrockets_Inc Jan. 29 at 6:02 PM
$RLYB This is the only thing green on my watchlist today. Blood red market day.
0 · Reply
estatebuyersmia
estatebuyersmia Jan. 28 at 7:23 PM
$RLYB its like being in a closet with no lights turned on waiting for the door to open...
1 · Reply
skyrockets_Inc
skyrockets_Inc Jan. 28 at 3:24 PM
$RLYB As a man of my word. Got most of my shares this morning, still trying to fill a portion of the remainder. Volume is extremely light and shares are hard to get. Kept getting jumped by algos. No one seems to be selling . I wonder why ..... :)
0 · Reply
skyrockets_Inc
skyrockets_Inc Jan. 28 at 12:29 AM
$RLYB ill be buying 50k more shares in the AM. Most risked reduced set up ive seen in a while.
1 · Reply
estatebuyersmia
estatebuyersmia Jan. 27 at 11:07 PM
$RLYB RALLYBIO isnt behaving like a healthy company right now but one that is buying time....
0 · Reply
estatebuyersmia
estatebuyersmia Jan. 27 at 10:58 PM
$RLYB PLAUSIBLE?
0 · Reply
estatebuyersmia
estatebuyersmia Jan. 27 at 10:56 PM
0 · Reply
estatebuyersmia
estatebuyersmia Jan. 27 at 10:56 PM
$RLYB READ
0 · Reply
estatebuyersmia
estatebuyersmia Jan. 27 at 10:43 PM
$RLYB MY TAKE
1 · Reply